MedTrace Logo

Cell-free DNA Methylation Markers for Cancer Screening

NCT03096938 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15000

Last updated 2017-12-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the role of cell-free DNA methylation markers in cancer screening.

Conditions

  • Cancer Screening

Interventions

DIAGNOSTIC_TEST

methylation markers screening

Cell-free DNA extraction from plasma samples-Bisulfite conversion of cfDNA-Determination of DNA methylation levels by deep sequencing-Sequencing data analysis

Sponsors & Collaborators

  • Sun Yat-sen University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
74 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-06-01
Primary Completion
2020-10-01
Completion
2021-05-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03096938 on ClinicalTrials.gov